BUY ERITROVIER-S ONLINE

Description

Infections produced by the following microorganisms:

Streptococcus pyogenes (ß-hemolytic group A): Infections of the upper and lower respiratory tract, infections of the skin and subcutaneous tissue of mild to moderate severity. As an alternative for the oral treatment of strep throat and long-term prophylaxis of rheumatic fever.

Α-Hemolytic Streptococcus (Viridans group): The use of erythromycin has been suggested for short-term prophylaxis against bacterial endocarditis, before dental procedures or upper respiratory surgical procedures in patients with congenital heart disease, rheumatic valve disease or acquired valvular disease and in those allergic to penicillin.

Staphylococcus aureus: Infections of the skin and subcutaneous tissue of mild to moderate severity.

Streptococcus pneumoniae (Diplococcus pneumoniae): Infections of the upper and lower respiratory tract such as otitis media, pharyngitis, mild to moderate pneumonia, etc.

Haemophilus influenzae: For the treatment of mild to moderate upper respiratory infections. Some strains are resistant to erythromycin alone, but are susceptible to the combination of erythromycin with sulfonamides.

Chlamydia trachomatis: For the treatment of urethritis in adults.

Corynebacterium diphtetheriae: As an adjuvant or auxiliary to antitoxins to prevent the appearance of carriers and for the eradication of these microorganisms.

Corynebacterium minutissimum: For the treatment of erythrasma.

Bordetella pertussis: Erythromycin is effective in killing the organism from the nasopharynx of infected people.

Mycoplasma pneumoniae: For the treatment of respiratory tract infections caused by said microorganism.

Indications

Eritrovier-S is commonly prescribed for:

• Respiratory Tract Infections: Such as pharyngitis, bronchitis, and pneumonia.
• Skin and Soft Tissue Infections: Including impetigo and cellulitis.
• Gastrointestinal Infections: Such as Campylobacter enteritis.
• Other Bacterial Infections: Including pertussis and diphtheria prophylaxis.

Key Features

• Effective Treatment: Targets a wide range of bacterial infections.
• Easy-to-Administer Suspension: Suitable for children and adults who have difficulty swallowing tablets.
• Precise Dosage: 250 mg of erythromycin per 5 mL, ensuring accurate administration.

Dosage and Administration

• Shake well before use.
• Administer using the measuring device provided, as directed by a healthcare provider.
• Typically taken every 6 to 8 hours, depending on the severity of the infection.
• May be taken with or without food; taking with food may reduce gastrointestinal discomfort.

Contraindications and Precautions

Contraindications:

• Allergy to erythromycin or other macrolide antibiotics.
• Severe liver disease or concurrent use of certain medications (e.g., statins or ergot derivatives).

Precautions:

• Inform your doctor of any liver conditions, allergies, or history of QT prolongation.
• Use with caution in patients with gastrointestinal disorders or electrolyte imbalances.
• Complete the full prescribed course to prevent resistance.

Side Effects

Common: Mild nausea, diarrhea, or abdominal discomfort.
Rare but Serious: Severe allergic reactions, liver dysfunction, or cardiac arrhythmias.
Seek medical attention if serious side effects occur.

Storage Instructions

• Store at room temperature (15–25°C).
• Keep the bottle tightly closed and protect from light.
• Keep out of reach of children.

Packaging

Supplied in a 100 mL bottle with detailed usage instructions and a measuring device.

Why Choose Eritrovier-S?

Eritrovier-S offers a reliable and convenient solution for bacterial infections, ensuring effective treatment through its macrolide formulation and user-friendly suspension format.